PCSK9 c.688_689delinsGG ;(p.L230G)

Variant ID: 1-55518353-CT-GG

NM_174936.3(PCSK9):c.688_689delinsGG;(p.L230G)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia.

Biomedicines
Bai, Zhengli Z; Xu, Menglong M; Mei, Ying Y; Hu, Tuo T; Zhang, Panpan P; Chen, Manman M; Lv, Wenxiu W; Lu, Chenchen C; Tan, Shuhua S
Publication Date: 2021-11-27

Variant appearance in text: PCSK9: L230G
PubMed Link: 34944600
Variant Present in the following documents:
  • Main text
  • biomedicines-09-01783.pdf
View BVdb publication page



Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia.

Biomedicines
Bai, Zhengli Z; Xu, Menglong M; Mei, Ying Y; Hu, Tuo T; Zhang, Panpan P; Chen, Manman M; Lv, Wenxiu W; Lu, Chenchen C; Tan, Shuhua S
Publication Date: 2021-11-27

Variant appearance in text: PCSK9: L230G
PubMed Link: 34944600
Variant Present in the following documents:
  • Main text
  • biomedicines-09-01783.pdf
View BVdb publication page